Assessment of Dental Implants Placed in Posterior Maxillary Ridge Using Densah Burs Versus Standard Drills
Launched by CAIRO UNIVERSITY · Jul 13, 2018
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
the densification of bone using the densah burs are thought to be improving the bone quality surrounding the implants thus increasing the primary stability and decreasing the marginal bone loss surrounding the implants comparing to the normal drilling techniques using the conventional implant drilling kit
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with partially edentulous in the posterior area of the maxilla, with a residual ridge that allowed insertion of ≤3.5 width implants.
- • Both sexes.
- • No intraoral soft and hard tissue pathology
- • No systemic condition that contraindicate implant placement
- Exclusion Criteria:
- • Sinus pathology.
- • Heavy smokers more than 20 cigarettes per day.
- • Patients with systemic disease that may affect normal healing.
- • Psychiatric problems
- • Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site
- • Immunodeficiency pathology, bruxism, stress situation (socially or professionally), emotional instability, and unrealistic aesthetic demands.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials